Kestra Medical Technologies today announced primary results from a post-approval study of its wearable cardioverter ...

Kestra Medical Technologies Ltd. ( ($KMTS) ) just unveiled an announcement. On November 10, 2025, Kestra Medical Technologies announced the ...

Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today announced ...

A study was conducted to compare cardiovascular and mortality outcomes following COVID-19 vs influenza infection using real-world data.

Kestra Medical (KMTS) announced primary results from the ASSURE WCD Clinical Evaluation Post-Approval Study, presented as a late-breaking science ...

Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia set to launch in NovemberTonmya is the first new FDA-approved ...